Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey.

PubWeight™: 4.09‹?› | Rank: Top 1%

🔗 View Article (PMID 17130393)

Published in Arch Intern Med on November 27, 2006

Authors

Varant Kupelian1, John T Wei, Michael P O'Leary, John W Kusek, Heather J Litman, Carol L Link, John B McKinlay, BACH Survery Investigators

Author Affiliations

1: New England Research Institutes, Watertown, MA 02472, USA. vkupelian@neriscience.com

Articles citing this

Measuring the urologic iceberg: design and implementation of the Boston Area Community Health (BACH) Survey. Eur Urol (2007) 3.32

Initial treatment of men with newly diagnosed lower urinary tract dysfunction in the Veterans Health Administration. Urology (2013) 2.60

Prostatic fibrosis is associated with lower urinary tract symptoms. J Urol (2012) 2.37

What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women. Eur Urol (2014) 2.32

The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors. Eur Urol (2013) 2.10

Finasteride reduces the risk of incident clinical benign prostatic hyperplasia. Eur Urol (2012) 1.89

Obesity increases and physical activity decreases lower urinary tract symptom risk in older men: the Osteoporotic Fractures in Men study. Eur Urol (2011) 1.81

Association between socioeconomic status (SES) and lower urinary tract symptom (LUTS) severity among black and white men. J Gen Intern Med (2011) 1.76

Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors. Curr Bladder Dysfunct Rep (2010) 1.74

Benign prostatic hyperplasia. Part 1--diagnosis. BMJ (2008) 1.70

Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis. Int J Clin Pract (2013) 1.61

Association between Lower Urinary Tract Symptoms and Vascular Risk Factors in Aging Men: The Hallym Aging Study. Korean J Urol (2010) 1.59

Lower urinary tract symptoms increase the risk of falls in older men. BJU Int (2009) 1.53

Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years. Urology (2008) 1.48

Risk factors for delay in symptomatic presentation: a survey of cancer patients. Br J Cancer (2014) 1.41

Treatment status and progression or regression of lower urinary tract symptoms in a general adult population sample. J Urol (2013) 1.40

A new approach to patients with lower urinary tract symptoms. Br J Gen Pract (2012) 1.39

Progression of lower urinary tract symptoms in older men: a community based study. J Urol (2010) 1.22

Incidence and progression of lower urinary tract symptoms in a large prospective cohort of United States men. J Urol (2012) 1.16

Prostatic fibrosis, lower urinary tract symptoms, and BPH. Nat Rev Urol (2013) 1.15

Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey. Urology (2009) 1.09

CXC-type chemokines promote myofibroblast phenoconversion and prostatic fibrosis. PLoS One (2012) 1.03

The effect of competing direct-to-consumer advertising campaigns on the use of drugs for benign prostatic hyperplasia: time series analysis. J Gen Intern Med (2014) 1.02

Sleep related problems and urological symptoms: testing the hypothesis of bidirectionality in a longitudinal, population based study. J Urol (2013) 1.01

Cohort profile: the Boston Area Community Health (BACH) survey. Int J Epidemiol (2012) 0.99

Relationship of lifestyle and clinical factors to lower urinary tract symptoms: results from Boston Area Community Health survey. Urology (2007) 0.99

Evaluating racial/ethnic disparities in lower urinary tract symptoms in men. J Urol (2011) 0.91

Drug treatment of urological symptoms: estimating the magnitude of unmet need in a community-based sample. BJU Int (2009) 0.91

Are statin medications associated with lower urinary tract symptoms in men and women? Results from the Boston Area Community Health (BACH) Survey. Ann Epidemiol (2011) 0.88

Incidence of lower urinary tract symptoms in a population-based study of men and women. Urology (2013) 0.88

Are physical activity, smoking and alcohol consumption associated with lower urinary tract symptoms in men or women? Results from a population based observational study. J Urol (2012) 0.86

Commonly used antihypertensives and lower urinary tract symptoms: results from the Boston Area Community Health (BACH) Survey. BJU Int (2011) 0.86

Psychosocial predictors of lower urinary tract symptom bother in black men: the Flint Men's Health Study. J Urol (2009) 0.86

Nonsteroidal antiinflammatory drug use and lower urinary tract symptoms: results from the Boston area community health survey. Am J Epidemiol (2011) 0.86

Prevalence, risk factors and the bother of lower urinary tract symptoms in China: a population-based survey. Int Urogynecol J (2015) 0.86

Intake of caffeinated, carbonated, or citrus beverage types and development of lower urinary tract symptoms in men and women. Am J Epidemiol (2013) 0.86

Urological symptom clusters and health-related quality-of-life: results from the Boston Area Community Health Survey. BJU Int (2009) 0.85

Associations between modest weight changes and onset and progression of lower urinary tract symptoms in two population-based cohorts. Urology (2011) 0.84

Dietary, but not supplemental, intakes of carotenoids and vitamin C are associated with decreased odds of lower urinary tract symptoms in men. J Nutr (2010) 0.84

Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome. Nat Rev Urol (2016) 0.84

Diagnosis and Treatment of Sleep Apnea in patients' homes: the rationale and methods of the "GoToSleep" randomized-controlled trial. J Clin Sleep Med (2012) 0.82

The influence of depression, anxiety and somatization on the clinical symptoms and treatment response in patients with symptoms of lower urinary tract symptoms suggestive of benign prostatic hyperplasia. J Korean Med Sci (2014) 0.82

Prevalence of post-micturition symptoms in association with lower urinary tract symptoms and health-related quality of life in men and women. BJU Int (2011) 0.82

Lifestyle and health factors associated with progressing and remitting trajectories of untreated lower urinary tract symptoms among elderly men. Prostate Cancer Prostatic Dis (2014) 0.82

A healthy bladder: a consensus statement. Int J Clin Pract (2011) 0.81

Race and ethnic differences in health beliefs about lower urinary tract symptoms. Nurs Res (2011) 0.81

Intakes of vitamins and minerals in relation to urinary incontinence, voiding, and storage symptoms in women: a cross-sectional analysis from the Boston Area Community Health survey. Eur Urol (2011) 0.80

Dietary macronutrient intake and lower urinary tract symptoms in women. Ann Epidemiol (2011) 0.79

Fluid manipulation among individuals with lower urinary tract symptoms: a mixed methods study. J Clin Nurs (2010) 0.78

Lower Urinary Tract Symptoms, Depression, Anxiety and Systemic Inflammatory Factors in Men: A Population-Based Cohort Study. PLoS One (2015) 0.78

Effectiveness of medical and surgical therapies for lower urinary tract symptoms in the community setting. BJU Int (2012) 0.78

Association of bowel habits with lower urinary tract symptoms in men: findings from the 2005-2006 and 2007-2008 National Health and Nutrition Examination Survey. J Urol (2012) 0.77

The difference of lower urinary tract symptoms between sympathetic hyperactive and hypoactive men. Int Neurourol J (2013) 0.77

New therapeutic strategies for the treatment of male lower urinary tract symptoms. Res Rep Urol (2016) 0.77

Talking with others about stigmatized health conditions: implications for managing symptoms. Qual Health Res (2012) 0.77

The Relationship between Depression, Anxiety, Somatization, Personality and Symptoms of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia. Psychiatry Investig (2014) 0.76

A critical review of recent clinical practice guidelines on the diagnosis and treatment of non-neurogenic male lower urinary tract symptoms. Can Urol Assoc J (2015) 0.76

Lower Urinary Tract Symptoms and Risk of Nonspine Fractures among Older Community Dwelling U.S. Men. J Urol (2016) 0.76

Lower urinary tract dysfunction in male Iraq and Afghanistan war veterans: association with mental health disorders: a population-based cohort study. Urology (2013) 0.76

The Impact of Lower Urinary Tract Symptoms on Quality of Life, Work Productivity, Depressive Symptoms, and Sexuality in Korean Men Aged 40 Years and Older: A Population-Based Survey. Int Neurourol J (2015) 0.75

Heritability of Lower Urinary Tract Symptoms in Men: A Twin Study. J Urol (2016) 0.75

Reproductive history and progression of lower urinary tract symptoms in women: results from a population-based cohort study. Urology (2014) 0.75

Lower Urinary Tract Symptoms and Risk of Bladder Cancer in Men: Results From the Health Professionals Follow-up Study. Urology (2015) 0.75

Cardiovascular Risk Factors and Ethnicity Are Independent Factors Associated with Lower Urinary Tract Symptoms. PLoS One (2015) 0.75

Depression and Its Severity Are Strongly Associated with Both Storage and Voiding Lower Urinary Tract Symptoms Independently of Prostate Volume. J Korean Med Sci (2015) 0.75

Lower urinary tract symptoms: thinking beyond the urinary tract. BMJ Case Rep (2014) 0.75

Does uroflowmetry parameter facilitate discrimination between detrusor underactivity and bladder outlet obstruction? Investig Clin Urol (2016) 0.75

Diagnosis and treatment patterns of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia in Murjani General Hospital, Central Kalimantan, Indonesia. Prostate Int (2016) 0.75

Evidence for the Impact of Diet, Fluid Intake, Caffeine, Alcohol and Tobacco on Lower Urinary Tract Symptoms: A Systematic Review. J Urol (2017) 0.75

Open-label, 9-month extension study investigating the uro-selective alpha-blocker silodosin in men with LUTS associated with BPH. World J Urol (2015) 0.75

Urinary Incontinence, Its Risk Factors, and Quality of Life: A Study among Women Aged 50 Years and above in a Rural Health Facility of West Bengal. J Midlife Health (2017) 0.75

Sociodemographic Factors Related to Lower Urinary Tract Symptoms in Men: A Korean Community Health Survey. Int Neurourol J (2017) 0.75

Patient's behavior and attitudes toward the management of benign prostatic hyperplasia among patients with the risk of disease progression: prospective study by "Prostate and Expectations of Treatment Epidemiology Research (PETER) study group". Wien Klin Wochenschr (2014) 0.75

Correlation of Prostate Gland Size and Uroflowmetry in Patients with Lower Urinary Tract Symptoms. J Clin Diagn Res (2017) 0.75

Prevalence, risk factors, and symptom bother of nocturia: a population-based survey in China. World J Urol (2014) 0.75

Articles by these authors

A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41

Prevalence of chronic kidney disease in the United States. JAMA (2007) 38.98

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81

Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med (2012) 24.06

Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med (2008) 18.60

Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99

Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem (2007) 13.80

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature (2009) 12.58

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med (2003) 11.25

Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med (2002) 10.52

Integrative molecular concept modeling of prostate cancer progression. Nat Genet (2006) 8.49

Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48

Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med (2010) 7.95

Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med (2007) 7.90

The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol (2003) 7.79

Autoantibody signatures in prostate cancer. N Engl J Med (2005) 7.56

Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA (2008) 7.50

FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22

Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol (2011) 6.54

Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell (2005) 6.04

Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int (2008) 5.90

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA (2011) 5.86

Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet (2006) 5.65

Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med (2009) 5.58

The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study. Ann Intern Med (2005) 5.45

Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care (2006) 5.44

Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. J Natl Cancer Inst (2006) 5.42

Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol (2011) 5.01

APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med (2013) 5.00

TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res (2006) 4.99

A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med (2012) 4.59

Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab (2002) 4.46

Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (2002) 4.34

Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol (2009) 4.16

Prediction of erectile function following treatment for prostate cancer. JAMA (2011) 3.92

Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71

Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med (2009) 3.69

Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. Mod Pathol (2007) 3.37

A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res (2008) 3.35

Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis (2008) 3.34

National utilization trends of partial nephrectomy for renal cell carcinoma: a case of underutilization? Urology (2006) 3.34

Measuring the urologic iceberg: design and implementation of the Boston Area Community Health (BACH) Survey. Eur Urol (2007) 3.32

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol (2003) 3.31

Differential adoption of laser prostatectomy for treatment of benign prostatic hyperplasia. Urology (2013) 3.31

Demographic and clinical characteristics of men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. J Urol (2002) 3.14

Use of advanced treatment technologies among men at low risk of dying from prostate cancer. JAMA (2013) 3.08

Prevalence of and risk factors for urine leakage in a racially and ethnically diverse population of adults: the Boston Area Community Health (BACH) Survey. Am J Epidemiol (2008) 3.02

The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med (2004) 2.94

The role of SPINK1 in ETS rearrangement-negative prostate cancers. Cancer Cell (2008) 2.87

Uric acid and long-term outcomes in CKD. Am J Kidney Dis (2009) 2.86

Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy. J Clin Oncol (2005) 2.84

Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial. Ann Intern Med (2004) 2.82

The increasing incidence of newborn circumcision: data from the nationwide inpatient sample. J Urol (2005) 2.76

The economic impact of chronic prostatitis. Arch Intern Med (2004) 2.74

Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab (2004) 2.73

Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71

Urinary TMPRSS2:ERG and PCA3 in an active surveillance cohort: results from a baseline analysis in the Canary Prostate Active Surveillance Study. Clin Cancer Res (2013) 2.70

The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. Eur Urol (2007) 2.70

Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med (2008) 2.66

A multicenter study of [-2]pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/ml prostate specific antigen range. J Urol (2011) 2.65

Normal, bound and nonbound testosterone levels in normally ageing men: results from the Massachusetts Male Ageing Study. Clin Endocrinol (Oxf) (2005) 2.63

Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation (2011) 2.62

Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA. Sci Transl Med (2011) 2.62

Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab (2007) 2.58

Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States. Clin Cancer Res (2009) 2.51

Urodynamic measures do not predict stress continence outcomes after surgery for stress urinary incontinence in selected women. J Urol (2008) 2.43

Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis (2012) 2.42

A population-level decline in serum testosterone levels in American men. J Clin Endocrinol Metab (2006) 2.41

Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer. Neoplasia (2006) 2.39

Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol (2004) 2.39

A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness. Cancer Epidemiol Biomarkers Prev (2010) 2.36

The rationale and design of the AASK cohort study. J Am Soc Nephrol (2003) 2.34

Nocturia and quality of life: results from the Boston area community health survey. Eur Urol (2011) 2.34

Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys (2006) 2.33

NCCN clinical practice guidelines in oncology: prostate cancer early detection. J Natl Compr Canc Netw (2010) 2.31

Sex steroids and all-cause and cause-specific mortality in men. Arch Intern Med (2007) 2.27

Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population. Urology (2011) 2.26

Validation of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary pain in both men and women. Urology (2009) 2.16

Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate cancer survivors. Urology (2010) 2.14

C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int (2005) 2.13

Comparison of measured GFR, serum creatinine, cystatin C, and beta-trace protein to predict ESRD in African Americans with hypertensive CKD. Am J Kidney Dis (2011) 2.11

Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. Am J Obstet Gynecol (2011) 2.09

Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a multicenter prospective study. Urology (2013) 2.08

Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab (2006) 2.08

Prostate cancer early detection. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2007) 2.06

Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc (2010) 2.03

Beyond PSA: the next generation of prostate cancer biomarkers. Sci Transl Med (2012) 2.00

Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of men. J Clin Endocrinol Metab (2007) 1.96

Prevalence of painful bladder symptoms and effect on quality of life in black, Hispanic and white men and women. J Urol (2007) 1.94

Racial treatment trends in localized/regional prostate carcinoma: 1992-1999. Cancer (2005) 1.93